General Study identifies KRAS G12C as a precision-medicine target in genitourinary cancersBy Healthcare Propulsion StaffAugust 29, 20260 A new research paper was published in Volume 17 of Oncotarget on August 19, 2026, titled “Incidence of KRAS G12C mutations in genitourinary…
